FENC

Fennec Pharmaceuticals INC

-$19.9M

Net Activity

Institutions Holding

91

Popularity Rank

#4647

Avg Weight

0.27%

Total Value

$99.7M

Ownership Trend

91 institutions currently hold FENC, with 52 net buyers and 39 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

39

Net Buying Institutions

52

Key Holders

View all 91 holding institutions

Quarterly Activity

Recent Activity

+$55.3M

Total Buy Value

$31.0M

Total Sell Value

New buy14
Trim19
Add38
Sold out20

52

Net Buyers

39

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$100K

Total Est. Value

10K shares

Planned Shares

Last Filed 2026-07-01
FilerFiling DateEst. Value
ROSTISLAV RAYKOV2026-07-01$100K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding FENNEC PHARMACEUTICALS INC (FENC)?
Major stakeholders currently include Rosalind Advisors, Inc. ($17.9M), Southpoint Capital Advisors LP ($16.9M), Solas Capital Management, LLC ($15.3M). Based on the latest 13F filings, there are a total of 91 tracked investment funds and institutions maintaining positions in FENC.
What is the overall institutional sentiment toward FENC recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $19.9M, driven by 52 managers accumulating shares while 39 reduced their exposure.
Which institutions have been selling or reducing their FENC positions?
In the latest period, 19 funds trimmed their holdings, and 20 managers completely exited their positions. The aggregate reported sell value was $31.0M.
Are there any notable investors adding FENC to their portfolios?
Yes, buying activity remains notable. 14 institutions opened new positions in {ticker}, and 38 existing holders added to their shares. The total reported buy value for the quarter amounted to $55.3M.

Related Stocks